FDA Approves Hemophilia B Drug "Rixubis"

The FDA has just approved the drug Rixubis [Coagulation Factor IX (Recombinant)] for people over the age of 16 suffering from hemophilia B. Hemophilia B is an inherited chronic blood disorder where the blood does not clot properly, it is caused by mutations in the Factor IX gene. The symptoms of hemophilia are characterized by serious bleeding (particularly in the joints) and easy bruising... Continue